Single Peptides

DSIP (10mg Vial) Dosage Protocol

DSIP (10mg Vial) Dosage Protocol

Quickstart Highlights

DSIP dosage protocols can help promote deep, restorative delta-wave sleep and support healthy stress response. Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring nonapeptide (9 amino acids) first isolated from rabbit brain for its ability to enhance slow-wave sleep[1]. Research indicates DSIP may improve sleep quality, normalize sleep architecture, reduce stress-related cortisol patterns, and support mood stabilization without next-day grogginess[2][3]. This educational protocol presents a once-daily subcutaneous evening approach using a practical dilution for clear insulin-syringe measurements.

  • Reconstitute: Add 3.0 mL bacteriostatic water → ~3.33 mg/mL concentration.
  • Typical daily range: 100–300 mcg once daily in the evening (gradual titration).
  • Easy measuring: At 3.33 mg/mL, 1 unit = 0.01 mL ≈ 33.3 mcg on a U-100 insulin syringe.
  • Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.
dsip_2

 Dosing & Reconstitution Guide

Standard / Gradual Approach (3 mL = ~3.33 mg/mL)

Week Daily Dose (mcg) Units (per injection) (mL)
Week 1 100 mcg 3 units (0.03 mL)
Week 2 150 mcg 5 units (0.05 mL)
Week 3 200 mcg 6 units (0.06 mL)
Weeks 4–8 250–300 mcg 8–9 units (0.08–0.09 mL)

Frequency: Inject once daily subcutaneously in the evening, approximately 30–60 minutes before bedtime[4]. For ≤10-unit (≤0.10 mL) administrations, consider 30- or 50-unit insulin syringes for improved readability.

Reconstitution Steps

  1. Draw 3.0 mL bacteriostatic water with a sterile syringe.
  2. Inject slowly down the vial wall; avoid foaming.
  3. Gently swirl/roll until dissolved (do not shake).
  4. Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Supplies Needed

Plan based on an 8–12 week nightly protocol with gradual titration.

  • Peptide Vials (DSIP, 10 mg each):
    • 8 weeks ≈ 1 vial (10 mg supports ~33–100 doses at 100–300 mcg)
    • 12 weeks ≈ 2 vials
  • Insulin Syringes (30- or 50-unit recommended for small volumes):
    • Per week: 7 syringes (1/day)
    • 8 weeks: 56 syringes
    • 12 weeks: 84 syringes
  • Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution.
    • 8 weeks (1 vial): 3 mL1 × 10 mL bottle
    • 12 weeks (2 vials): 6 mL1 × 10 mL bottle
  • Alcohol Swabs: One for the vial stopper + one for the injection site each day.
    • Per week: 14 swabs (2/day)
    • 8 weeks: 112 swabs → recommend 2 × 100-count boxes
    • 12 weeks: 168 swabs → recommend 2 × 100-count boxes

Protocol Overview

Concise summary of the once-daily evening regimen.

  • Goal: Support improved sleep quality, enhanced delta-wave (slow-wave) sleep, and stress modulation over time[2][3].
  • Schedule: Daily subcutaneous injections in the evening for 8–12 weeks.
  • Dose Range: 100–300 mcg daily with gradual titration.
  • Reconstitution: 3.0 mL per 10 mg vial (~3.33 mg/mL) for accurate unit measurements.
  • Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.

Dosing Protocol

Suggested nightly titration approach.

  • Start: 100 mcg nightly; increase by ~50 mcg every 1–2 weeks as tolerated.
  • Target: 250–300 mcg nightly by Weeks 4–8.
  • Frequency: Once per day (subcutaneous), 30–60 minutes before bedtime.
  • Cycle Length: 8–12 weeks; consider a break after the cycle.
  • Timing: Evening dosing to align with natural sleep onset; rotate injection sites.

Storage Instructions

Proper storage preserves peptide quality.

  • Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure[5].
  • Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); prepare aliquots if needed and avoid freeze–thaw.
  • Allow vials to reach room temperature before opening to reduce condensation uptake.

Important Notes

  • Practical considerations for consistency and safety.
    • Use new sterile insulin syringes; dispose in a sharps container.
    • Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation[6].
    • Inject slowly; wait a few seconds before withdrawing the needle.
    • Document daily dose and site rotation to maintain consistency.
    • Avoid other sedatives during DSIP use to clearly evaluate its effects on sleep.

How This Works

DSIP acts as a neuromodulator of the sleep-wake cycle and stress response. Administration consistently increases delta-wave (slow-wave) sleep in EEG recordings[2], suggesting it promotes the initiation and maintenance of deep, non-REM sleep. DSIP readily crosses the blood-brain barrier to exert central effects[7] and may enhance inhibitory neuronal activity or modulate sleep-regulating brain regions. Additionally, DSIP attenuates ACTH and corticosterone release in response to stress, indicating an effect on the hypothalamic-pituitary-adrenal axis[8]. Unlike conventional sedatives, DSIP tends to normalize sleep architecture without next-day grogginess[3].

Potential Benefits & Side Effects

bservations from preclinical and clinical literature.

  • Supports improved sleep quality and increased slow-wave (delta) sleep duration[2][3].
  • May help normalize disrupted sleep patterns in chronic insomnia[3].
  • Shows potential for stress reduction and mood support through HPA axis modulation[8][9].
  • Remarkably safe profile: animal studies found no lethal dose even at extremely high doses; human studies report only mild, transient side effects (occasional headache or nausea)[1][8].
  • Occasional mild injection-site reactions (redness/itch) may occur with subcutaneous administration.

Lifestyle Factors

  • Complementary strategies for best outcomes.
    • Maintain consistent sleep-wake schedules to reinforce circadian rhythm.
    • Limit caffeine and screen exposure in the evening hours.
    • Create a dark, cool sleep environment to support natural melatonin production.
    • Prioritize stress management techniques and regular physical activity during daytime hours.

Injection Technique

General subcutaneous guidance from clinical best-practice resources[6][10].

  • Clean the vial stopper and skin with alcohol; allow to dry.
  • Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue[6].
  • Do not aspirate for subcutaneous injections; inject slowly and steadily.
  • Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy[10].
  • Using a 30- or 50-unit insulin syringe improves accuracy when measuring small volumes (3–9 units).

Recommended Source

Why Amino Labs?

  • Third-party tested: Each batch includes Certificate of Analysis (COA) verifying purity and composition.
  • Consistent quality: ISO-aligned manufacturing and handling standards ensure reliable product integrity.
  • Cold-chain integrity: Temperature-controlled shipping and storage throughout fulfillment process.
  • Research-grade purity: Suitable for educational and research applications requiring high-quality peptides.

Note: Product availability and specifications subject to change. Verify current product details on supplier website.

Shop at Amino Labs

Important Note

This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment.

References

Schoenenberger GA, Monnier M (1977)
— Characterization of a delta-electroencephalogram (-sleep)-inducing peptide. Proc Natl Acad Sci USA
European Journal of Anaesthesiology (2001)
— Delta sleep-inducing peptide: editorial review of mechanisms and clinical context
Schneider-Helmert D, Schoenenberger GA (1983)
— Effects of DSIP in man: multifunctional psychophysiological properties. Neuropsychobiology
Sudakov KV et al. (2004)
— Delta-sleep-inducing peptide sequelae: stress protective effect. Ann N Y Acad Sci
Schneider-Helmert D (1981)
— Acute and delayed effects of DSIP on human sleep behavior. Int J Clin Pharmacol Ther Toxicol
Graf MV, Kastin AJ (1984)
— Delta-sleep-inducing peptide (DSIP): a review. Neurosci Biobehav Rev
Iyer KS et al. (1988)
— Sleep-inducing effect of low doses of DSIP in rats. Indian J Exp Biol
Manning MC et al. (2010)
— Stability of protein pharmaceuticals: an update. Pharm Res
Wang W (2000)
— Lyophilization and development of solid protein pharmaceuticals. Int J Pharm
Yehuda S, Carasso RL (1988)
— DSIP: brain mechanisms and function. Int J Neurosci
Khvatova EM et al. (2003)
— Delta sleep-inducing peptide: effect on oxidative stress in brain during different models. Biull Eksp Biol Med
CDC
— Vaccine administration: subcutaneous route (angle/site; no aspiration)
NCBI Bookshelf
— Medication Administration: Subcutaneous Injections (Open RN Nursing Skills)
Amino Labs
— BPC-157 (5 mg) product page (quality and batch documentation)